prnewswire.comNeurocrine Biosciences to Present at Upcoming Investor Conferences in September9 days ago
benzinga.comA Glimpse Into The Expert Outlook On Neurocrine Biosciences Through 14 Analystsabout 2 months ago
benzinga.comInsider Decision Making Waves At Neurocrine Biosciences: CHARLES KEVIN GORMAN Exercises Options, Realizing $03 months ago
benzinga.comNeurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target4 months ago
benzinga.comFARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday4 months ago
cnbc.comStocks making the biggest moves premarket: Palantir Technologies, Ford Motor, Vertex Pharmaceuticals, DoorDash and more4 months ago
CashuNeurocrine Biosciences Engages Investors at Upcoming Healthcare Conferences in September 20257 days ago
CashuNeurocrine Biosciences Highlights Neuroscience Commitment at September 2025 Investor Conferences8 days ago
CashuNeurocrine Biosciences (NBIX) Prepares for Key Investor Conferences in September 202510 days ago